-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
TROPOS: designing a clinical trial to evaluate the oral corticosteroid-sparing effect of a biologic in severe asthma
William W Busse, Millie Wang, Jennifer Gibson, Mattis Gottlow, Martin Braddock & Gene Colice
Protocol: Clinical Investigation
-
TROPOS: designing a clinical trial to evaluate the oral corticosteroid-sparing effect of a biologic in severe asthma
William W Busse, Millie Wang, Jennifer Gibson, Mattis Gottlow, Martin Braddock & Gene Colice
Protocol: Clinical Investigation
-
TROPOS: designing a clinical trial to evaluate the oral corticosteroid-sparing effect of a biologic in severe asthma
William W Busse, Millie Wang, Jennifer Gibson, Mattis Gottlow, Martin Braddock & Gene Colice
Protocol: Clinical Investigation
-
TROPOS: designing a clinical trial to evaluate the oral corticosteroid-sparing effect of a biologic in severe asthma
William W Busse, Millie Wang, Jennifer Gibson, Mattis Gottlow, Martin Braddock & Gene Colice
Protocol: Clinical Investigation
-
TROPOS: designing a clinical trial to evaluate the oral corticosteroid-sparing effect of a biologic in severe asthma
William W Busse, Millie Wang, Jennifer Gibson, Mattis Gottlow, Martin Braddock & Gene Colice
Protocol: Clinical Investigation
-
TROPOS: designing a clinical trial to evaluate the oral corticosteroid-sparing effect of a biologic in severe asthma
William W Busse, Millie Wang, Jennifer Gibson, Mattis Gottlow, Martin Braddock & Gene Colice
Protocol: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ivabradine for the treatment of heart failure
Lynn Elzir, Eileen OMeara, Simon de Denus & Jean-Claude Tardif
Review: Clinical Trail Outcomes: Clinical Investigation
-
Quality of life measures in patients on rhinosinusitis trials
Eduardo Lehrer-Coriat, Franklin Marino-Sanchez, Isam Alobid, Joaquim Mullol
Clinical Trail Methodology: Clinical Investigation
-
Quality of life measures in patients on rhinosinusitis trials
Eduardo Lehrer-Coriat, Franklin Marino-Sanchez, Isam Alobid, Joaquim Mullol
Clinical Trail Methodology: Clinical Investigation
-
Quality of life measures in patients on rhinosinusitis trials
Eduardo Lehrer-Coriat, Franklin Marino-Sanchez, Isam Alobid, Joaquim Mullol
Clinical Trail Methodology: Clinical Investigation
-
Quality of life measures in patients on rhinosinusitis trials
Eduardo Lehrer-Coriat, Franklin Marino-Sanchez, Isam Alobid, Joaquim Mullol
Clinical Trail Methodology: Clinical Investigation
-
Quality of life measures in patients on rhinosinusitis trials
Eduardo Lehrer-Coriat, Franklin Marino-Sanchez, Isam Alobid, Joaquim Mullol
Clinical Trail Methodology: Clinical Investigation
-
Quality of life measures in patients on rhinosinusitis trials
Eduardo Lehrer-Coriat, Franklin Marino-Sanchez, Isam Alobid, Joaquim Mullol
Clinical Trail Methodology: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation